Previous studies have revealed that by downregulating MMP2 expression through the NF‐κB pathway, GKN1 inhibits metastasis in GC cells, suggesting that it may be a potential therapeutic target for gastric cancer.35, 36. Here, NFKB1 is linked to gastric cancer.